Fapon drives innovation in the U.S. clinical market

Learn about Fapon's key products tailored for the U.S. in vitro diagnostics market and its approach to meeting local needs. Narayan Krishnaswami, Regional Marketing Director, and Nick Guan, Vice President of Molecular Diagnostics R&D, discuss the company's clinical diagnostics strategy in the U.S. and highlight the contributions of Fapon's research centers in San Francisco and Boston.

Explore Fapon's future plans for expanding and strengthening its presence in the U.S., including innovations in Alzheimer's disease diagnostics and upcoming antibodies for vitamin D testing. Discover how Fapon is committed to catering to the unique demands of the U.S. market through continuous innovation and strategic localization. Plus, hear about Fapon's development plan for its highlighted product of the year, the Teloscript reverse transcriptase, and about the company's focus on infectious diseases such as influenza, COVID-19, syphilis, and HIV.
This video was filmed at ADLM 2024.